Here, we report the first identification of two germline mutations in <i>BRCA1</i> and <i>MSH2</i> in a woman with mixed serous papillary adenocarcinoma and endometrioid carcinoma. This evidence concerns the gene MSH2 and papillary serous cystadenocarcinoma.